BSE · ISHITADR

Ishita Drugs & Industries Ltd.

Sector: Healthcare · ISIN: INE806D01016

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,062

of 5,084 stocks

▼ 91W

Peak #4,025 · 27 Sep 2026

Operating in Healthcare, Ishita Drugs & Industries Ltd. is seeing revenue slip, commands a premium earnings multiple, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap

21.53 Cr

P/E Ratio

27.69

P/B Ratio

1.86

ROE

6.73%

ROCE

9.81%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	3.15 Cr	3.06 Cr	3.14 Cr	3.07 Cr
Net Profit	23.02 L	17.74 L	15.55 L	14.33 L
EPS	0.77	0.59	0.52	0.48
Operating Profit	30.49 L	29.58 L	20.76 L	22.52 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

50.04%

Public

49.96%

PUBLIC BREAKDOWN

Individuals

48.04%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
10 May 2019	Other	E.G.M.
10 Sep 2001	Dividend	NIL Dividend - Rs. - 0.0000

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs